AI-Powered Clinical Study Design and Clinical Development Partner

armstrong clinical

Helping innovators make smarter, faster, and more confident development decisions through integrated clinical expertise and AI-enabled strategic intelligence.

We help biotech and medtech companies accelerate drug development through integrated clinical development strategy, regulatory consulting, translational medicine, clinical trial design, and AI-driven development intelligence. Our team combines pharmaceutical clinical development expertise with AI-powered analytics to support faster development decisions, stronger regulatory alignment, and improved probability of clinical success. Unlike traditional CRO models, we focus on strategic decision-making that directly impacts development timelines, regulatory outcomes, and asset value.

What we Offer

Our model combines senior pharmaceutical development expertise with AI-enabled analytics to help biotech companies navigate critical development decisions across clinical strategy, regulatory planning, translational medicine, and evidence generation

When you access Armstrong Clinical, you are gaining an extension of your team by leveraging the expertise of professionals in Clinical Study Design, Translational Medicine, Regulatory Strategy, Manufacturing, Phase I-IV Development Strategy, Pricing, Market Access, and Study Implementation. Before your first study begins, define your path to market with an early-phase study design that supports subsequent clinical development decisions.


Current & Previous Clients


Why work with us

What we bring to the table

We add value across the clinical development lifecycle from Phase I studies through to Phase IV. Some key skills that our team brings to the table include:


Sound Regulatory Insights

Trial Planning and Design

Decision Gated Clinical Development Strategy

Understanding Complexity

Execution and Location Advice

Writing, Publishing and Submissions

Partners

client feedbacks

Testimonials

Don’t take our word for it – here’s what our clients say


  • “Our engagement with Armstrong Clinical has been extremely valuable. The advice was pragmatic and provided us with a range of options based on our objectives, timelines and budget. The stage-gated approach to developing our clinical development strategy provided clarity and metrics that are unique to our program and will guide our decision-making process.”
    Dr Rachel de las Heras – Program Director 
    Queensland Brain Institute, University of Queensland 
  • “Armstrong Clinical provided top-notch assistance with our clinical development program. Their advice regarding our early phase clinical trial helped us meet our development timelines.”
    John – Sr. Director
    Large Multinational Pharma

Latest Blog Posts

At Armstrong Clinical we are committed to providing our audience latest information about various aspects of clinical development, especially as it applies in the Australian context.